
    
      The first 4 subjects received rituximab weekly for 4 weeks at the standard dose of 375 mg/m2,
      starting 6 weeks after ASCT transplant.

      After an observation period to assess acute and late toxicity for the first 4 subjects,
      subsequent subjects received induction as above followed by an additional 4 week course at
      6-months post-ASCT.
    
  